Thomson Reuters announced the latest addition to its Cortellis suite, an informatics solution for drug discovery and development—Cortellis Data Fusion. Cortellis Data Fusion utilizes linked data technologies—frameworks that allow content to be shared across applications and enterprise or community boundaries—connecting users with data from internal proprietary systems as well as third-party resources to address Big Data challenges.
We last wrote about Cortellis in regards to its Clinical Trials Intelligence analytics tool, which mines data across published trial results in medical publications, internal databases at Thomson and more, to inform clinical trials decisions.
Read the full release here.
